Actuate Therapeutics, Inc.
ACTU
$2.15
-$0.12-5.29%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/24/2026
-
ACCESS Newswire
3/18/2026
-
MarketBeat
3/10/2026
-
Ticker Report
3/9/2026
-
Globe Newswire
3/7/2026
-
MarketBeat
3/4/2026
-
Globe Newswire
2/24/2026
-
Globe Newswire
2/14/2026
-
MarketBeat
2/6/2026
-
Zacks Investment Research
1/21/2026
-
GuruFocus
1/21/2026
-
GuruFocus
1/21/2026
-
The Fly
1/21/2026
-
The Fly
1/21/2026
-
Globe Newswire
1/20/2026
-
Ticker Report
1/20/2026
-
Ticker Report
1/19/2026
-
MarketBeat
1/17/2026
-
MarketBeat
1/15/2026
-
TipRanks Financial Blog
1/12/2026
-
GuruFocus
1/12/2026
-
TipRanks Financial Blog
1/12/2026
-
The Fly
1/8/2026
-
MarketBeat
1/7/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
817 887 8455
Address
1751 River Run
Fort Worth, TX 76107
Fort Worth, TX 76107
Country
Year Founded
Business Description
Sector
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company’s lead product candidate is elraglusib...
more